#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Toxoplasmosis – seroprevalence and trend over 10 years


Authors: J. Ficik
Authors‘ workplace: Ústav klinickej mikrobiológie, Ústredná vojenská nemocnica SNP-FN v Ružomberku, Slovenská republika
Published in: Epidemiol. Mikrobiol. Imunol. 74, 2025, č. 1, s. 11-19
Category: Original Papers
doi: https://doi.org/10.61568/emi/11-6445/20250128/139683

Overview

Objective: Determination of the seroprevalence of toxoplasmosis in patients tested in the network Unilabs Slovakia Ltd over 10 years (2011–2020).

Material and Methods: In the study period, 142,088 patients from all over Slovakia underwent targeted serological screening for toxoplasmosis. Serum samples were tested for IgG and IgM antibodies by electrochemiluminescence assays. A total of 469,824 of tests were performed during the study period in three central laboratories of the Alpha Medical company (now Unilabs Slovakia Ltd) located in Bratislava, Ružomberok-Likavka, and Stropkov.

Results: The seroprevalence of toxoplasmosis has shown a slightly upward trend (for IgM antibodies), remaining stable for IgG class antibodies, neither declining nor rising. An upward trend in positive IgM antibodies appeared not only in general, but also in pregnant women. When calculated per 100,000 population, the IgG seroprevalence has shown an upward 10-year trend for the whole of Slovakia.

Conclusion: The results of this study have evidenced that toxoplasmosis is far from declining in Slovakia; just on the contrary, it can be reasonably assumed that its incidence is slowly rising, especially among pregnant women, which, from the point of view of public health, is worthy of further and more detailed investigation.

Keywords:

seroprevalence – Toxoplasma gondii – Toxoplasmosis – Neuropsychiatric disorders – pregnancy


Sources
  1. Milne G, Webster JP, Walker M. Toxoplasma gondii: An Underestimated Threat? Trends in Parasitology, 2020;36(12):959–969. doi: 10.1016/j.pt.2020.08.005.
  2. Hlaváčová J, Flegr J, Řežábek K, et al. Association between latent toxoplasmosis and fertility parameters of men. Andrology, 2021;9(3):854–862. doi: 10.1111/andr.12969.
  3. Flegr J, Klapilová, K, Kaňková Š. Toxoplasmosis can be a sexually transmitted infection with serious clinical consequences. Not all routes of infection are created equal. Med. Hypotheses, 2014;83(3):286–289. doi: 10.1016/j.mehy.2014.05.019.
  4. Tyebji S, Seizova S, Hannan AJ, et al. Toxoplasmosis: A pathway to neuropsychiatric disorders. Neurosci Biobehav Rev, 2019;96:72–92. doi: 10.1016/j.neubiorev.2018.11.012.
  5. Aspöck H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl, 1992;84:32–37.
  6. Janitschke K. Toxoplasmose-Vorsorge bei Schwangeren und Neugeborenen in Deutschland. Mitt. Österr. Ges. Tropenmed. Parasitol,1996;18:19–24.
  7. Ondriska F, Boldiš V, Ondrušková M, et al. Prevencia toxoplazmózy v tehotnosti na Slovensku. Newslab, 2020;11(2):87–88. Dostupné na www: https://www.newslab.sk/wp-content/uplo- ads/2020/09/NEWSLAB_2-2020_PP_Ondriska_87_88str.pdf
  8. Peyron F, L‘ollivier C, Mandelbrot L, et al. Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens, 2019;8(1):24. doi: 10.3390/pathogens8010024.
  9. ECDC, Congenital toxoplasmosis – Annual Epidemiological Report for 2020. Dostupné na www: https://www.ecdc.europa. eu/sites/default/files/documents/AER-congenital-toxoplasmosis-2020.pdf.
  10. Assolini JP, Concato VM, Gonçalves MD, et al. Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications. Parasitol Res, 2017;116(6):1603–1615. doi: 10.1007/ s00436-017-5458-2.
  11. Správa o činnosti NRC pre toxoplazmózu, 2018. Dostupné na www: https://www.uvzsr.sk/documents/d/uvz/vyrocna_spra- va_nrc_2018-pdf.
  12. Správa o činnosti NRC pre toxoplazmózu, 2019. Dostupné na www: https://www.uvzsr.sk/documents/d/uvz/vyrocna_spra- va_nrc_2019-pdf.
  13. Správa o činnosti NRC pre toxoplazmózu, 2020. Dostupné na www: https://www.uvzsr.sk/documents/d/uvz/vyrocna_spra- va_nrc_2020.
  14. Rahmanian V, Rahmanian K, Jahromi A,S et al. Seroprevalence of Toxoplasma gondii infection: An umbrella review of updated systematic reviews and meta-analyses. J Family Med Prim Care, 2020;9(8):3848–3855. doi: 10.4103/jfmpc.jfmpc_753_20.
  15. Smith NC, Goulart C, Hayward JA, et al. Control of human toxoplasmosis. Int J Parasitol, 2021;51(2–3):95–121. doi: 10.1016/j. ijpara.2020.11.001.
  16. Okusaga O, Langenberg P, Sleemi A, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophrenia Research, 2011;133(1–3):150–155. doi: 10.1016/j.schres.2011.08.006.
  17. Správa o činnosti NRC pre toxoplazmózu, 2017. Dostupné na www: https://www.uvzsr.sk/documents/d/uvz/vyrocna_spra- va_nrc_2017-pdf.
  18. Štatistický úrad Slovenskej republiky. Banskobystrický kraj – charakteristika regiónu: Ekonomické a sociálne špecifiká, 2023. Dostupné na www: https://slovak.statistics.sk/wps/portal/ext/ themes/regional/bansko%20bystricky%20kraj/about

Do redakce došlo dne 3. 7. 2024.

Adresa pro korespondenci:
prim. MUDr. Jozef Ficik, MPH
Ústav klinickej mikrobiológie
Ústredná vojenská nemocnica SNP-FN v Ružomberku
ul. gen. Miloša Vesela
21 034 26 Ružomberok Slovenská republika
e-mail:
ficikj@uvn.sk

Labels
Hygiene and epidemiology Medical virology Clinical microbiology

Article was published in

Epidemiology, Microbiology, Immunology


Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#